| [1] |
PAPADOPOULOU S K. Sarcopenia: a contemporary health problem among older adult populations[J]. Nutrients, 2020, 12(5): 1293.
|
| [2] |
DAI S Y, SHU D B, MENG F J, et al. Higher risk of sarcopenia in older adults with type 2 diabetes: NHANES 1999-2018[J]. Obes Facts, 2023, 16(3): 237-248.
|
| [3] |
王金涛, 胡 坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-532.
|
| [4] |
DE CARVALHO F G, JUSTICE J N, DE FREITAS E C, et al. Adipose tissue quality in aging: how structural and functional aspects of adipose tissue impact skeletal muscle quality[J]. Nutrients, 2019, 11(11): 2553.
|
| [5] |
WANG M N, TAN Y, SHI Y F, et al. Diabetes and sarcopenic obesity: pathogenesis, diagnosis, and treatments[J]. Front Endocrinol, 2020, 11: 568.
|
| [6] |
杜怡宁, 杨 青. 老年肌少症性肥胖研究进展[J]. 国际老年医学杂志, 2023, 44(6): 734-738.
|
| [7] |
KARANTH S D, WASHINGTON C, CHENG T D, et al. Inflammation in relation to sarcopenia and sarcopenic obesity among older adults living with chronic comorbidities: results from the national health and nutrition examination survey 1999-2006[J]. Nutrients, 2021, 13(11): 3957.
|
| [8] |
BATSIS J A, MACKENZIE T A, JONES J D, et al. Sarcopenia, sarcopenic obesity and inflammation: results from the 1999-2004 National Health and Nutrition Examination Survey[J]. Clin Nutr, 2016, 35(6): 1472-1483.
|
| [9] |
KANG M G, JUNG H W, KIM B J. A link between systemic low-grade inflammation and frailty in older adults: clinical evidence from a nationwide population-based study[J]. Korean J Intern Med, 2024, 39(6): 1011-1020.
|
| [10] |
BIOLO G, CEDERHOLM T, MUSCARITOLI M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia[J]. Clin Nutr, 2014, 33(5): 737-748.
|
| [11] |
KOSHIKAWA M, HARADA M, NOYAMA S, et al. Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications[J]. BMC Cardiovasc Disord, 2020, 20(1): 228.
|
| [12] |
LIVSHITS G, KALINKOVICH A. A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity[J]. Ageing Res Rev, 2023, 86: 101852.
|
| [13] |
CHEN L K, WOO J, ASSANTACHAI P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307.
|
| [14] |
GARVEY W T, MECHANICK J I, BRETT E M, et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity[J]. Endocr Pract, 2016, 22(): 1-203.
|
| [15] |
LYNCH G M, MURPHY C H, DE MARCO CASTRO E, et al. Inflammation and metabolism: the role of adiposity in sarcopenic obesity[J]. Proc Nutr Soc, 2020: 1-13.
|
| [16] |
CLEASBY M E, JAMIESON P M, ATHERTON P J. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities[J]. J Endocrinol, 2016, 229(2): R67-R81.
|
| [17] |
YING L, ZHANG Q, YANG Y M, et al. A combination of serum biomarkers in elderly patients with sarcopenia: a cross-sectional observational study[J]. Int J Endocrinol, 2022, 2022: 4026940.
|
| [18] |
TEIXEIRA L A C, AVELAR N C P, PARENTONI A N, et al. Inflammatory biomarkers in older women with obesity, sarcopenia, and sarcopenic obesity[J]. J Am Med Dir Assoc, 2023, 24(10): 1562-1564.
|
| [19] |
杜 婧, 赵家军. 非酒精性脂肪肝合并肌少症研究进展[J]. 中国实用内科杂志, 2024,44(5): 424-430, 440.
|
| [20] |
AKASH M S H, REHMAN K, LIAQAT A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J]. J Cell Biochem, 2018, 119(1): 105-110.
|
| [21] |
LEVINE M E, CRIMMINS E M. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning[J]. Obesity, 2012, 20(10): 2101-2106.
|
| [22] |
MOHAMMAD I J, KASHANIAN S, RAFIPOUR R, et al. Evaluation of the relationship of cytokines concentrations tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in obese diabetics and obese non-diabetics: a comparative study[J]. Biotechnol Appl Biochem, 2024, 71(2): 272-279.
|
| [23] |
EBRAHIMI M, HEIDARI-BAKAVOLI A R, SHOEIBI S, et al. Association of serum hs-CRP levels with the presence of obesity, diabetes mellitus, and other cardiovascular risk factors[J]. J Clin Lab Anal, 2016, 30(5): 672-676.
|
| [24] |
孙家镇, 高静媛, 盛丽春, 等. 中老年2型糖尿病合并肌少症与NLR等炎症标志物的相关性[J]. 中国骨质疏松杂志, 2024, 30(5): 679-683.
|
| [25] |
BIAN A L, HU H Y, RONG Y D, et al. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α[J]. Eur J Med Res, 2017, 22(1): 25.
|
| [26] |
黄安乐, 卜子涵, 薛梦婷, 等. 肌少症患者外周血炎性因子的Meta分析[J]. 中国骨质疏松杂志, 2021, 27(7): 969-975.
|
| [27] |
HE Y, DUAN W R, XU P, et al. Exploring the impact of interleukins on sarcopenia development: a systematic review and meta-analysis[J]. Exp Gerontol, 2024, 193: 112480.
|
| [28] |
YANG C W, LI C I, LI T C, et al. Correction: association of sarcopenic obesity with higher serum high-sensitivity C-reactive protein levels in Chinese older males-a community-based study (Taichung community health study-elderly, TCHS-E)[J]. PLoS One, 2015, 10(8): e0136069.
|
| [29] |
MALISZEWSKA K, ADAMSKA-PATRUNO E, KRĘTOWSKI A. The interplay between muscle mass decline, obesity, and type 2 diabetes[J]. Pol Arch Intern Med, 2019, 129(11): 809-816.
|
| [30] |
TRINH B, RASMUSSEN S J, BRØGGER-JENSEN M E, et al. Inhibition of basal IL-6 activity promotes subcutaneous fat retention in humans during fasting and postprandial states[J]. Cell Rep Med, 2025, 6(4): 102042.
|
| [31] |
FAN J J, KOU X J, YANG Y, et al. microRNA-regulated proinflammatory cytokines in sarcopenia[J]. Mediators Inflamm, 2016, 2016: 1438686.
|
| [32] |
柯义兵, 阿布都克热木·达吾提, 郭浩然, 等. 骨骼肌萎缩相关分子机制及信号通路研究进展[J]. 生理学报, 2024, 76(6): 1056-1068.
|
| [33] |
刘 竞, 丁国宪. 骨骼肌肌间脂肪浸润在代谢相关疾病中的研究进展[J]. 南京医科大学学报(自然科学版), 2024, 44(5): 719-725.
|